DXJ:NYE-WisdomTree Japan Hedged Equity Fund (USD)

ETF | Japan Stock |

Last Closing

USD 109.03

Change

-1.65 (-1.49)%

Market Cap

N/A

Volume

0.50M

Analyst Target

N/A
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-10-07 )

Largest Industry Peers for Japan Stock

Symbol Name Price(Change) Market Cap
FLJP Franklin FTSE Japan ETF

-0.32 (-1.05%)

USD 2.18B
DBJP Xtrackers MSCI Japan Hedged Eq..

-0.87 (-1.17%)

USD 0.41B
FLJH Franklin FTSE Japan Hedged ETF

-0.47 (-1.48%)

USD 0.08B
DFJ WisdomTree Japan SmallCap Divi..

-0.71 (-0.89%)

N/A
EWJ iShares MSCI Japan ETF

-0.84 (-1.17%)

N/A
GSJY Goldman Sachs ActiveBeta® Jap..

-0.44 (-1.09%)

N/A
HEWJ iShares Currency Hedged MSCI J..

-0.62 (-1.45%)

N/A
JPXN iShares JPX-Nikkei 400 ETF

-0.92 (-1.20%)

N/A
SCJ iShares MSCI Japan Small-Cap E..

-0.66 (-0.84%)

N/A

ETFs Containing DXJ

XNAV FundX Aggressive ETF 7.46 % 0.00 %

-0.61 (-0.89%)

N/A
GTAA 0.00 % 1.25 %

N/A

N/A

Market Performance

  Market Performance vs. Industry/Classification (Japan Stock) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 23.93% 90% A- 82% B
Dividend Return N/A N/A N/A N/A N/A
Total Return 23.93% 90% A- 82% B
Trailing 12 Months  
Capital Gain 26.91% 90% A- 71% C-
Dividend Return N/A N/A N/A N/A N/A
Total Return 26.91% 90% A- 71% C-
Trailing 5 Years  
Capital Gain 119.29% 90% A- 85% B
Dividend Return N/A N/A N/A N/A N/A
Total Return 119.29% 90% A- 85% B
Average Annual (5 Year Horizon)  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) N/A N/A N/A N/A N/A
Risk Adjusted Return N/A N/A N/A N/A N/A
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:

There is nothing we particularly dislike